RNAi revised - Target mRNA-dependent enhancement of gene silencing

Nucleic Acids Research

Volumn 43, Issue 22, 2015, Pages 10623-10632

  Dornseifer, Simon ^a   Willkomm, Sarah ^a,b   Far, Rosel Kretschmer Kazemi ^a   Liebschwager, Janine ^a   Beltsiou, Foteini ^a   Frank, Kirsten ^a   Laufer, Sandra D ^a,c   Martinetz, Thomas ^a   Sczakiel, Georg ^a   Claussen, Jens Christian ^a,d   Restle, Tobias ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d JACOBS UNIVERSITY BREMEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARGONAUTE 2 PROTEIN; MESSENGER RNA; ARGONAUTE PROTEIN; EIF2C2 PROTEIN, HUMAN; SMALL INTERFERING RNA;

ARTICLE; COMPUTER MODEL; CONCENTRATION RESPONSE; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; RNA CLEAVAGE; RNA INTERFERENCE; STEADY STATE; TIME; BIOLOGICAL MODEL; COMPUTER SIMULATION; HELA CELL LINE; KINETICS; METABOLISM;

ARGONAUTE PROTEINS; COMPUTER SIMULATION; HELA CELLS; HUMANS; KINETICS; MODELS, GENETIC; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 84975313687     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkv1200     Document Type: Article

References (75)

1. Stefani, G. and Slack, F.J. (2008) Small non-coding RNAs in animal development. Nat. Rev. Mol. Cell Biol., 9, 219-230.
2. Esquela-Kerscher, A. and Slack, F.J. (2006) Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer, 6, 259-269.
3. Tili, E., Michaille, J.J. and Calin, G.A. (2008) Expression and function of micro-RNAs in immune cells during normal or disease state. Int. J. Med. Sci., 5, 73-79.
4. Lu, M., Zhang, Q., Deng, M., Miao, J., Guo, Y., Gao, W. and Cui, Q. (2008) An analysis of human microRNA and disease associations. PloS one, 3, e3420.
5. Napoli, C., Lemieux, C. and Jorgensen, R. (1990) Introduction of a chimeric chalcone synthase gene into petunia results in reversible co-suppression of homologous genes in trans. Plant Cell, 2, 279-289.
6. van der Krol, A.R. (1990) Flavonoid genes in petunia: addition of a limited number of gene copies may lead to a suppression of gene expression. Plant Cell Online, 2, 291-299.
7. Romano, N. and Macino, G. (1992) Quelling: transient inactivation of gene expression in Neurospora crassa by transformation with homologous sequences. Mol Microbiol, 6, 3343-3353.
8. Lindbo, J.A., Silva-Rosales, L., Proebsting, W.M. and Dougherty, W.G. (1993) Induction of a highly specific antiviral state in transgenic plants: implications for regulation of gene expression and virus resistance. Plant Cell, 5, 1749-1759.
9. Lee, R.C., Feinbaum, R.L. and Ambros, V. (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell, 75, 843-854.
10. Fire, A., Xu, S., Montgomery, M.K., Kostas, S.A., Driver, S.E. and Mello, C.C. (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature, 391, 806-811.
11. Wilson, R.C. and Doudna, J.A. (2013) Molecular mechanisms of RNA interference. Annu. Rev. Biophys., 42, 217-239.
12. Tiemann, K. and Rossi, J.J. (2009) RNAi-based therapeutics-current status, challenges and prospects. EMBO Mol. Med., 1, 142-151.
13. Hammond, S.M., Bernstein, E., Beach, D. and Hannon, G.J. (2000) An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature, 404, 293-296.
14. Elbashir, S.M., Lendeckel, W. and Tuschl, T. (2001) RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev., 15, 188-200.
15. Jinek, M. and Doudna, J.A. (2009) A three-dimensional view of the molecular machinery of RNA interference. Nature, 457, 405-412.
16. Macfarlane, L.A. and Murphy, P.R. (2010) MicroRNA: biogenesis, function and role in cancer. Curr. Genomics, 11, 537-561.
17. Ghildiyal, M. and Zamore, P.D. (2009) Small silencing RNAs: an expanding universe. Nat. Rev. Genet., 10, 94-108.
18. Nykanen, A., Haley, B. and Zamore, P.D. (2001) ATP requirements and small interfering RNA structure in the RNA interference pathway. Cell, 107, 309-321.
19. Meister, G., Landthaler, M., Patkaniowska, A., Dorsett, Y., Teng, G. and Tuschl, T. (2004) Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol. Cell, 15, 185-197.
20. Liu, J., Carmell, M.A., Rivas, F.V., Marsden, C.G., Thomson, J.M., Song, J.J., Hammond, S.M., Joshua-Tor, L. and Hannon, G.J. (2004) Argonaute2 is the catalytic engine of mammalian RNAi. Science, 305, 1437-1441.
21. Tolia, N.H. and Joshua-Tor, L. (2007) Slicer and the argonautes. Nat. Chem. Biol., 3, 36-43.
22. Haley, B. and Zamore, P.D. (2004) Kinetic analysis of the RNAi enzyme complex. Nat. Struct. Mol. Biol., 11, 599-606.
23. Rivas, F.V., Tolia, N.H., Song, J.J., Aragon, J.P., Liu, J., Hannon, G.J. and Joshua-Tor, L. (2005) Purified Argonaute2 and an siRNA form recombinant human RISC. Nat. Struct. Mol. Biol., 12, 340-349.
24. Hutvagner, G. and Zamore, P.D. (2002) A microRNA in a multiple-turnover RNAi enzyme complex. Science, 297, 2056-2060.
25. Sen, G.L. and Blau, H.M. (2005) Argonaute 2/RISC resides in sites of mammalian mRNA decay known as cytoplasmic bodies. Nat. Cell Biol., 7, 633-636.
26. Jakymiw, A., Lian, S., Eystathioy, T., Li, S., Satoh, M., Hamel, J.C., Fritzler, M.J. and Chan, E.K. (2005) Disruption of GWbodies impairs mammalian RNA interference. Nat. Cell. Biol., 7, 1267-1274.
27. MacRae, I.J., Ma, E., Zhou, M., Robinson, C.V. and Doudna, J.A. (2008) In vitro reconstitution of the human RISC-loading complex. Proc. Natl. Acad. Sci. U. S. A., 105, 512-517.
28. Eulalio, A., Huntzinger, E. and Izaurralde, E. (2008) GW182 interaction with Argonaute is essential for miRNA-mediated translational repression and mRNA decay. Nat. Struct. Mol. Biol., 15, 346-353.
29. Grosshans, H. and Chatterjee, S. (2010) MicroRNAses and the regulated degradation of mature animal miRNAs. Adv. Exp. Med. Biol., 700, 140-155.
30. Fabian, M.R. and Sonenberg, N. (2012) The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC. Nat. Struct. Mol. Biol., 19, 586-593.
31. Bergstrom, C.T., McKittrick, E. and Antia, R. (2003) Mathematical models of RNA silencing: unidirectional amplification limits accidental self-directed reactions. Proc. Natl. Acad. Sci. U. S. A., 100, 11511-11516.
32. Groenenboom, M.A., Maree, A.F. and Hogeweg, P. (2005) The RNA silencing pathway: the bits and pieces that matter. PLoS Comput. Biol., 1, 155-165.
33. Raab, R.M. and Stephanopoulos, G. (2004) Dynamics of gene silencing by RNA interference. Biotechnol. Bioeng., 88, 121-132.
34. Vohradsky, J., Panek, J. and Vomastek, T. (2010) Numerical modelling of microRNA-mediated mRNA decay identifies novel mechanism of microRNA controlled mRNA downregulation. Nucleic Acids Res., 38, 4579-4585.
35. Gokhale, S.A. and Gadgil, C.J. (2012) Analysis of miRNA regulation suggests an explanation for 'unexpected' increase in target protein levels. Mol. Biosyst., 8, 760-765.
36. Bartlett, D.W. and Davis, M.E. (2006) Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imaging. Nucleic Acids Res., 34, 322-333.
37. Bartlett, D.W. and Davis, M.E. (2007) Effect of siRNA nuclease stability on the in vitro and in vivo kinetics of siRNA-mediated gene silencing. Biotechnol. Bioeng., 97, 909-921.
38. Bartlett, D.W., Su, H., Hildebrandt, I.J., Weber, W.A. and Davis, M.E. (2007) Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging. Proc. Natl. Acad. Sci. U. S. A., 104, 15549-15554.
39. Cuccato, G., Polynikis, A., Siciliano, V., Graziano, M., di Bernardo, M. and di Bernardo, D. (2011) Modeling RNA interference in mammalian cells. BMC Syst. Biol., 5, 19.
40. Larsson, E., Sander, C. and Marks, D. (2010) mRNA turnover rate limits siRNA and microRNA efficacy. Mol. Syst. Biol., 6, 433.
41. Wang, Y., Sheng, G., Juranek, S., Tuschl, T. and Patel, D.J. (2008) Structure of the guide-strand-containing argonaute silencing complex. Nature, 456, 209-213.
42. Wang, Y., Juranek, S., Li, H., Sheng, G., Tuschl, T. and Patel, D.J. (2008) Structure of an argonaute silencing complex with a seed-containing guide DNA and target RNA duplex. Nature, 456, 921-926.
43. Wang, Y., Juranek, S., Li, H., Sheng, G., Wardle, G.S., Tuschl, T. and Patel, D.J. (2009) Nucleation, propagation and cleavage of target RNAs in Ago silencing complexes. Nature, 461, 754-761.
44. Schirle, N.T. and MacRae, I.J. (2012) The crystal structure of human Argonaute2. Science, 336, 1037-1040.
45. Elkayam, E., Kuhn, C.D., Tocilj, A., Haase, A.D., Greene, E.M., Hannon, G.J. and Joshua-Tor, L. (2012) The structure of human argonaute-2 in complex with miR-20a. Cell, 150, 100-110.
46. Nakanishi, K., Weinberg, D.E., Bartel, D.P. and Patel, D.J. (2012) Structure of yeast Argonaute with guide RNA. Nature, 486, 368-374.
47. Schirle, N.T., Sheu-Gruttadauria, J. and MacRae, I.J. (2014) Structural basis for microRNA targeting. Science, 346, 608-613.
48. Deerberg, A., Willkomm, S. and Restle, T. (2013) Minimal mechanistic model of siRNA-dependent target RNA slicing by recombinant human Argonaute 2 protein. Proc. Natl. Acad. Sci. U. S. A., 110, 17850-17855.
49. Veldhoen, S., Laufer, S.D., Trampe, A. and Restle, T. (2006) Cellular delivery of small interfering RNA by a non-covalently attached cell-penetrating peptide: quantitative analysis of uptake and biological effect. Nucleic Acids Res., 34, 6561-6573.
50. Reynolds, A., Leake, D., Boese, Q., Scaringe, S., Marshall, W.S. and Khvorova, A. (2004) Rational siRNA design for RNA interference. Nat. Biotechnol., 22, 326-330.
51. Laufer, S.D. and Restle, T. (2008) Peptide-mediated cellular delivery of oligonucleotide-based therapeutics in vitro: quantitative evaluation of overall efficacy employing easy to handle reporter systems. Curr. Pharm. Des., 14, 3637-3655.
52. Laufer, S.D., Recke, A.L., Veldhoen, S., Trampe, A. and Restle, T. (2009) Noncovalent peptide-mediated delivery of chemically modified steric block oligonucleotides promotes splice correction: quantitative analysis of uptake and biological effect. Oligonucleotides, 19, 63-80.
53. Laufer, S.D., Detzer, A., Sczakiel, G. and Restle, T. (2010) Selected strategies for the delivery of silencing RNA in vitro and in vivo. In: Erdmann, VA and Barciszewski, J (eds). RNA Technologies and Their Applications. Springer, pp. 29-58.
54. Kihara, T., Yoshida, N., Kitagawa, T., Nakamura, C., Nakamura, N. and Miyake, J. (2010) Development of a novel method to detect intrinsic mRNA in a living cell by using a molecular beacon-immobilized nanoneedle. Biosens. Bioelectron., 26, 1449-1454.
55. White, A.K., VanInsberghe, M., Petriv, O.I., Hamidi, M., Sikorski, D., Marra, M.A., Piret, J., Aparicio, S. and Hansen, C.L. (2011) High-throughput microfluidic single-cell RT-qPCR. Proc. Natl. Acad. Sci. U. S. A., 108, 13999-14004.
56. Fox, B.C., Devonshire, A.S., Baradez, M.O., Marshall, D. and Foy, C.A. (2012) Comparison of reverse transcription-quantitative polymerase chain reaction methods and platforms for single cell gene expression analysis. Anal. Biochem., 427, 178-186.
57. Hoops, S., Sahle, S., Gauges, R., Lee, C., Pahle, J., Simus, N., Singhal, M., Xu, L., Mendes, P. and Kummer, U. (2006) COPASI-a COmplex PAthway SImulator. Bioinformatics, 22, 3067-3074.
58. Raj, A., Peskin, C.S., Tranchina, D., Vargas, D.Y. and Tyagi, S. (2006) Stochastic mRNA synthesis in mammalian cells. PLoS Biol., 4, e309.
59. Homann, M., Nedbal, W. and Sczakiel, G. (1996) Dissociation of long-chain duplex RNA can occur via strand displacement in vitro: biological implications. Nucleic Acids Res., 24, 4395-4400.
60. Wünsche, W. and Sczakiel, G. (2005) The activity of siRNA in mammalian cells is related to the kinetics of siRNA-target recognition in vitro: mechanistic implications. J. Mol. Biol., 345, 203-209.
61. Wang, D., Zhang, Z., O'Loughlin, E., Lee, T., Houel, S., O'Carroll, D., Tarakhovsky, A., Ahn, N.G. and Yi, R. (2012) Quantitative functions of Argonaute proteins in mammalian development. Genes Dev., 26, 693-704.
62. Velculescu, V.E., Madden, S.L., Zhang, L., Lash, A.E., Yu, J., Rago, C., Lal, A., Wang, C.J., Beaudry, G.A., Ciriello, K.M. et al. (1999) Analysis of human transcriptomes. Nat. Genet., 23, 387-388.
63. Harborth, J., Elbashir, S.M., Vandenburgh, K., Manninga, H., Scaringe, S.A., Weber, K. and Tuschl, T. (2003) Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing. Antisense Nucleic Acid Drug Dev., 13, 83-105.
64. Hu, X., Hipolito, S., Lynn, R., Abraham, V., Ramos, S. and Wong-Staal, F. (2004) Relative gene-silencing efficiencies of small interfering RNAs targeting sense and antisense transcripts from the same genetic locus. Nucleic Acids Res., 32, 4609-4617.
65. Krueger, U., Bergauer, T., Kaufmann, B., Wolter, I., Pilk, S., Heider-Fabian, M., Kirch, S., Artz-Oppitz, C., Isselhorst, M. and Konrad, J. (2007) Insights into effective RNAi gained from large-scale siRNA validation screening. Oligonucleotides, 17, 237-250.
66. Guo, H., Ingolia, N.T., Weissman, J.S. and Bartel, D.P. (2010) Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature, 466, 835-840.
67. Wee, L.M., Flores-Jasso, C.F., Salomon, W.E. and Zamore, P.D. (2012) Argonaute divides its RNA guide into domains with distinct functions and RNA-binding properties. Cell, 151, 1055-1067.
68. Grimson, A., Farh, K.K., Johnston, W.K., Garrett-Engele, P., Lim, L.P. and Bartel, D.P. (2007) MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell, 27, 91-105.
69. Kretschmer-Kazemi Far, R. and Sczakiel, G. (2003) The activity of siRNA in mammalian cells is related to structural target accessibility: a comparison with antisense oligonucleotides. Nucleic Acids Res., 31, 4417-4424.
70. Overhoff, M., Alken, M., Far, R.K., Lemaitre, M., Lebleu, B., Sczakiel, G. and Robbins, I. (2005) Local RNA target structure influences siRNA efficacy: a systematic global analysis. J. Mol. Biol., 348, 871-881.
71. Brown, K.M., Chu, C.Y. and Rana, T.M. (2005) Target accessibility dictates the potency of human RISC. Nat. Struct. Mol. Biol., 12, 469-470.
72. Dornseifer, S. and Sczakiel, G. (2013) Computational identification of biologically functional non-hairpin GC-helices in human Argonaute mRNA. BMC Bioinformatics, 14, 122.
73. Moyed, H.S. and Bertrand, K.P. (1983) hipA, a newly recognized gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis. J. Bacteriol., 155, 768-775.
74. Lewis, K. (2010) Persister cells. Annu. Rev. Microbiol., 64, 357-372.
75. Sharma, S.V., Lee, D.Y., Li, B., Quinlan, M.P., Takahashi, F., Maheswaran, S., McDermott, U., Azizian, N., Zou, L., Fischbach, M.A. et al. (2010) A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell, 141, 69-80.